MY8600271A - Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them - Google Patents

Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them

Info

Publication number
MY8600271A
MY8600271A MY271/86A MY8600271A MY8600271A MY 8600271 A MY8600271 A MY 8600271A MY 271/86 A MY271/86 A MY 271/86A MY 8600271 A MY8600271 A MY 8600271A MY 8600271 A MY8600271 A MY 8600271A
Authority
MY
Malaysia
Prior art keywords
derivatives
mercapto
novel
preparation
treatment
Prior art date
Application number
MY271/86A
Other languages
English (en)
Inventor
Pier Giogio Dr Ferrini
Richard Dr Goschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MY8600271A publication Critical patent/MY8600271A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MY271/86A 1978-04-11 1986-12-30 Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them MY8600271A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU79412 1978-04-11

Publications (1)

Publication Number Publication Date
MY8600271A true MY8600271A (en) 1986-12-31

Family

ID=19728887

Family Applications (1)

Application Number Title Priority Date Filing Date
MY271/86A MY8600271A (en) 1978-04-11 1986-12-30 Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them

Country Status (24)

Country Link
US (3) US4461770A (hu)
EP (1) EP0004648B1 (hu)
JP (1) JPS54135769A (hu)
KR (2) KR820002314B1 (hu)
AT (1) AT376971B (hu)
AU (1) AU532402B2 (hu)
CS (1) CS220324B2 (hu)
CY (1) CY1302A (hu)
DD (1) DD142712A5 (hu)
DE (1) DE2963572D1 (hu)
DK (1) DK148879A (hu)
ES (5) ES479490A0 (hu)
FI (1) FI65066C (hu)
GR (1) GR71193B (hu)
HK (1) HK87285A (hu)
HU (1) HU182018B (hu)
IL (1) IL57040A (hu)
MY (1) MY8600271A (hu)
NO (1) NO148926C (hu)
NZ (1) NZ190153A (hu)
PL (2) PL125972B1 (hu)
PT (1) PT69460A (hu)
SU (2) SU1259962A3 (hu)
ZA (1) ZA791702B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US5955480A (en) * 1996-11-20 1999-09-21 Merck & Co., Inc. Triaryl substituted imidazoles, compositions containing such compounds and methods of use
CN1211381C (zh) * 1997-04-24 2005-07-20 奥索·麦克尼尔药品公司 用于治疗炎性疾病的取代咪唑
US6040320A (en) * 1997-06-30 2000-03-21 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
DE19842833B4 (de) * 1998-09-18 2005-04-14 Merckle Gmbh 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de) 2001-02-19 2002-08-29 Merckle Gmbh Chem Pharm Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de) * 2002-08-20 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
US20080293726A1 (en) 2005-07-06 2008-11-27 Sepracor Inc. Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
CN103588659A (zh) 2006-03-31 2014-02-19 赛诺维信制药公司 手性酰胺和胺的制备
EP1894925A1 (en) * 2006-08-24 2008-03-05 Merckle Gmbh Imidazole compounds having an antiinflammatory effect

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
US3714179A (en) * 1970-09-08 1973-01-30 Searle & Co 1-alkyl-2-furfurylthioimidazoles and congeners
JPS5343958B2 (hu) * 1972-07-29 1978-11-24
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
DK16778A (da) * 1977-02-09 1978-08-10 Du Pont Imidazolderivater deres anvendelser og fremstilling
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4308277A (en) * 1978-08-10 1981-12-29 Ciba-Geigy Corporation 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
EP0004648B1 (de) 1982-08-25
ES8403877A1 (es) 1984-04-01
DE2963572D1 (en) 1982-10-21
ES8303355A1 (es) 1983-02-01
AU4599479A (en) 1979-10-18
ATA266179A (de) 1984-06-15
FI791158A (fi) 1979-10-12
KR820002315B1 (ko) 1982-12-17
ZA791702B (en) 1980-04-30
CY1302A (en) 1985-12-06
ES8505352A1 (es) 1985-05-16
PL125972B1 (en) 1983-06-30
NO148926B (no) 1983-10-03
AT376971B (de) 1985-01-25
ES8504737A1 (es) 1985-05-01
FI65066B (fi) 1983-11-30
EP0004648A2 (de) 1979-10-17
SU991945A3 (ru) 1983-01-23
NZ190153A (en) 1981-05-15
NO148926C (no) 1984-01-11
CS220324B2 (en) 1983-03-25
DD142712A5 (de) 1980-07-09
ES8504738A1 (es) 1985-05-01
US4608382A (en) 1986-08-26
DK148879A (da) 1979-10-12
PL125882B1 (en) 1983-06-30
IL57040A0 (en) 1979-07-25
JPS6339594B2 (hu) 1988-08-05
EP0004648A3 (en) 1979-11-14
ES528579A0 (es) 1985-05-01
ES515766A0 (es) 1984-04-01
IL57040A (en) 1984-08-31
ES528581A0 (es) 1985-05-16
US4461770A (en) 1984-07-24
ES528580A0 (es) 1985-05-01
US4584310A (en) 1986-04-22
HK87285A (en) 1985-11-15
PT69460A (en) 1979-05-01
JPS54135769A (en) 1979-10-22
PL214745A1 (hu) 1980-06-16
NO791228L (no) 1979-10-12
SU1259962A3 (ru) 1986-09-23
FI65066C (fi) 1984-03-12
ES479490A0 (es) 1983-02-01
HU182018B (en) 1983-12-28
AU532402B2 (en) 1983-09-29
GR71193B (hu) 1983-04-11
KR820002314B1 (ko) 1982-12-17

Similar Documents

Publication Publication Date Title
DE2964397D1 (en) Process for the preparation of 4-pyridone-3-carboxylic acids, 1-cyclopropyl-4-pyridone-3-carboxylic acid derivatives and medicines containing them
DE2960222D1 (en) Phenoxyalkylcarboxylic-acid derivatives, process for their preparation and medicaments containing them
ZA792937B (en) Process for the preparation of spheroidally shaped products
DE2962122D1 (en) 17-alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses
DE2962631D1 (en) Process for the sterilization of pharmaceutical products
IL57662A (en) Acyl-esters of carnitine,process for their preparation and pharmaceutical compositions comprising them
MY8600271A (en) Novel mercaptoimidazole derivatives process for their preparation, mercapto-imidazole derivatives for the treatment of inflammatory disorders, and pharmaceutical products containing them
PT71676A (en) Process for the preparation of new derivatives of 1h-indolhaving pharmaceutical properties
IL56944A (en) Process for the preparation of cis-hexahydrodibenzopyranones and 3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives
DE2960954D1 (en) 1-aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
EP0007576A3 (en) Esters of stilbene derivatives, process for their preparation, intermediate products and their preparation, use of the esters as insecticides
DE2964209D1 (en) Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them
DE2961983D1 (en) Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
IL65810A0 (en) Substituted tryptamine derivatives of thienyloxypropanolamines,process for their preparation,pharmaceutical products based on these compounds and the use of these products
DE2964198D1 (en) Indanamine derivatives, process for their preparation and medicaments containing them
GB2037185B (en) Dielectric product and process for the preparation thereof
ZA79271B (en) 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications
CY1339A (en) Process for the manufacture of novel benzazole derivatives,pharmaceutical preparations containing these derivatives and their use
DE2961524D1 (en) Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations
DE2960037D1 (en) Isoquinolines, process for their preparation and their use for the preparation of medicines
GB2033902B (en) 1,6-naphthyridine derivatives process for the production thereof and pharmaceutical composition containing such derivatives
SG28885G (en) Novel azathianaphthalene derivatives,process for their manufacture,pharmaceutical preparations containing them and their use
IL60268A0 (en) Process for the preparation of 3,3-dimethyl-cyclopropane-1,1,2-tricarboxylic acid derivatives,and -halogeno-nitriles as new intermediate products for this process and their preparation